They demonstrated that high-risk group patients had significantly poorer renal prognosis than other groups using the RRS, and that RRS was an independent renal prognostic factor in 86 Japanese biopsy-confirmed MPO-ANCA-positive GN patients. The gene discussed is MPO; the disease is ganglioneuroma.